Stimart Tryn 4
4 · AbCellera Biologics Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Stimart Tryn
Chief Legal Officer
Transactions
- Sale
Common Shares
2021-06-09$25.50/sh−1,000,000$25,500,000→ 250 total
Holdings
- 250(indirect: By Spouse)
Common Shares
Footnotes (2)
- [F1]On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
- [F2]The sale of the shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act"), to the extent of 500 Shares, with the purchase by the Reporting Person of 250 Shares at a price of $20 per share on December 15, 2020, and the purchase by the Reporting Person's spouse of 250 Shares at a price of $20 per share on December 15, 2020, as reported previously on the Reporting Person's Form 4 filed on December 17, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act.